...
首页> 外文期刊>BioMed research international >A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
【24h】

A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs

机译:基于环糊精的携带者进行综合综述,用于递送化学治疗性细胞毒性抗癌药物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Most of the cytotoxic chemotherapeutic agents have poor aqueous solubility. These molecules are associated with poor physicochemical and biopharmaceutical properties, which makes' the formulation difficult. An important approach in this regard is the use of combination of cyclodextrin and nanotechnology in delivery system. This paper provides an overview of limitations associated with anticancer drugs, their complexation with cyclodextrins, loading/encapsulating the complexed drugs into carriers, and various approaches used for the delivery. The present review article aims to assess the utility of cydodextrin-based carriers like liposomes, niosomes, nanoparticles, micelles, millirods, and siRNA for delivery of antineoplastic agents. These systems based on cyclodextrin complexation and nanotechnology will camouflage the undesirable properties of drug and lead to synergistic or additive effect. Cyclodextrin-based nanotechnology seems to provide better therapeutic effect and sustain long life of healthy and recovered cells. Still, considerable study on delivery system and administration routes of cyclodextrin-based carriers is necessary with respect to their pharmacokinetics and toxicology to substantiate their safety and efficiency. In future, it would be possible to resolve the conventional and current issues associated with the development and commercialization of antineoplastic agents.
机译:大多数细胞毒性化学治疗剂具有差的水溶性。这些分子与物理化学和生物化学和生物化学性质差,这使得“制剂变得困难。在这方面的一个重要方法是在输送系统中使用环糊精和纳米技术的组合。本文概述了与抗癌药物相关的限制,它们与环糊精的络合,将复合药物装入载体中,以及用于递送的各种方法。本综述文章旨在评估基于脂质体,憩室,纳米粒子,胶束,毫粒子和siRNA等基于Cydodextrin的载体的效用,用于递送抗肿瘤剂。这些基于环糊精络合和纳米技术的系统将伪装药物的不希望的性能并导致协同或添加剂效应。基于环糊精的纳米技术似乎提供更好的治疗效果,维持健康和回收细胞的长寿。仍然,对于其药代动力学和毒理学来说,需要大量研究基于环糊精的载体的递送系统和给药途径,以证实它们的安全性和效率。未来,可以解决与抗肿瘤剂的开发和商业化相关的常规和当前问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号